Title : Treatment of MDA5-positive dermatomyositis complicated by gangrenous cholecystitis with tofacitinib.

Pub. Date : 2022 May 15

PMID : 35570320






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Treatment of MDA5-positive dermatomyositis complicated by gangrenous cholecystitis with tofacitinib. tofacitinib interferon induced with helicase C domain 1 Homo sapiens
2 CASE PRESENTATION: We report a case of anti-MDA5 antibody-positive dermatomyositis that was relieved after treatment with tofacitinib, during which gallbladder gangrene and suppurative cholecystitis occurred. tofacitinib interferon induced with helicase C domain 1 Homo sapiens
3 CONCLUSIONS: Tofacitinib is effective in the treatment of anti-MDA5 antibody-positive dermatomyositis, but the risk of infection is increased. tofacitinib interferon induced with helicase C domain 1 Homo sapiens